Dr. Michael Har-Noy is Patenting Technology Of Limitless Value

22 Sep

Conventional cancer treatment methods, such as surgery, chemotherapy, and radiation, do not have the ability to target and kill metastatic tumor cells wherever they reside in the patient’s body. However, Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies, Ltd., a biotech company in Israel, says that the human immune system, if properly manipulated, may be capable of doing this. Dr. Michael Har-Noy goes on to state that if one could harness the ability of a patient’s immune system to target and eliminate metastatic cells, the result may be an actual complete cure.

At Immunovative Therapies, Ltd., Dr. Michael Har-Noy has developed a unique process he terms the “Mirror EffectTM. The Mirror EffectTM technology represents a break-through in our ability to target tumors with direct immune responses and to disrupt the ability of cancer cells to avoid these responses. The development of the Mirror EffectTM and the synthesis of compounds that utilize it have the potential to spawn an entire new industry of medicine. Dr. Michael Har-Noy goes on to indicate that by patenting this technology properly, his company can create immensely profitable and marketable drugs.

Dr. Michael Har-Noy and his team at Immunovative Therapies, Ltd. have been working with their patent attorneys to build a portfolio that captures the immense depth and scope of the Mirror EffectTM and characterizes its use to manipulate the immune system to treat some of the most refractory diseases described in modern medicine. Dr. Michael Har-Noy indicates that the patent portfolio Immunovative Therapies is developing will not only involve protection of the company’s products and manufacturing techniques but will have the potential to create a completely new industry based on controlling and manipulating the human immune system.

Ultimately, Immunovative Therapies, Ltd.’s patent portfolio will likely introduce a new field of oncology and completely change the way cancer is treated. Dr. Michael Har-Noy believes that this new technology will therefore be of virtually limitless value.

Advertisements
%d bloggers like this: